174 related articles for article (PubMed ID: 12507893)
1. Regulation of EMAP II by hypoxia.
Matschurat S; Knies UE; Person V; Fink L; Stoelcker B; Ebenebe C; Behrensdorf HA; Schaper J; Clauss M
Am J Pathol; 2003 Jan; 162(1):93-103. PubMed ID: 12507893
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of endothelial monocyte-activating polypeptide-II in acute lung inflammation.
Journeay WS; Janardhan KS; Singh B
Inflamm Res; 2007 May; 56(5):175-81. PubMed ID: 17393072
[TBL] [Abstract][Full Text] [Related]
4. Prostate adenocarcinoma cells release the novel proinflammatory polypeptide EMAP-II in response to stress.
Barnett G; Jakobsen AM; Tas M; Rice K; Carmichael J; Murray JC
Cancer Res; 2000 Jun; 60(11):2850-7. PubMed ID: 10850427
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
[TBL] [Abstract][Full Text] [Related]
6. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
Berger AC; Alexander HR; Tang G; Wu PS; Hewitt SM; Turner E; Kruger E; Figg WD; Grove A; Kohn E; Stern D; Libutti SK
Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
[TBL] [Abstract][Full Text] [Related]
7. Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.
Murray JC; Heng YM; Symonds P; Rice K; Ward W; Huggins M; Todd I; Robins RA
J Leukoc Biol; 2004 May; 75(5):772-6. PubMed ID: 14982944
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo.
Murray JC; Barnett G; Tas M; Jakobsen A; Brown J; Powe D; Clelland C
Am J Pathol; 2000 Dec; 157(6):2045-53. PubMed ID: 11106577
[TBL] [Abstract][Full Text] [Related]
9. Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha.
Crippa L; Gasparri A; Sacchi A; Ferrero E; Curnis F; Corti A
Cancer Res; 2008 Feb; 68(4):1154-61. PubMed ID: 18281491
[TBL] [Abstract][Full Text] [Related]
10. The impact of Meth A fibrosarcoma derived EMAP II on dendritic cell migration.
Haridas S; Bowers M; Tusano J; Mehojah J; Kirkpatrick M; Burnham DK
Cytokine; 2008 Nov; 44(2):304-9. PubMed ID: 18951814
[TBL] [Abstract][Full Text] [Related]
11. Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines.
Bottoni A; Vignali C; Piccin D; Tagliati F; Luchin A; Zatelli MC; Uberti EC
J Cell Physiol; 2007 Aug; 212(2):293-7. PubMed ID: 17443684
[TBL] [Abstract][Full Text] [Related]
12. Expression of EMAP II in the developing and adult mouse.
Knies UE; Kröger S; Clauss M
Apoptosis; 2000 Apr; 5(2):141-51. PubMed ID: 11232242
[TBL] [Abstract][Full Text] [Related]
13. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis.
Knies UE; Behrensdorf HA; Mitchell CA; Deutsch U; Risau W; Drexler HC; Clauss M
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12322-7. PubMed ID: 9770485
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH.
Chang SY; Ko HJ; Heo TH; Kang CY
Mol Pharmacol; 2005 May; 67(5):1534-43. PubMed ID: 15710745
[TBL] [Abstract][Full Text] [Related]
15. Cell-surface associated p43/endothelial-monocyte-activating-polypeptide-II in hepatocellular carcinoma cells induces apoptosis in T-lymphocytes.
Faisal W; Symonds P; Panjwani S; Heng Y; Murray JC
Asian J Surg; 2007 Jan; 30(1):13-22. PubMed ID: 17337366
[TBL] [Abstract][Full Text] [Related]
16. Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature.
Kayton ML; Libutti SK
Curr Opin Investig Drugs; 2001 Jan; 2(1):136-8. PubMed ID: 11527006
[TBL] [Abstract][Full Text] [Related]
17. Intratumoural expression of TNF-R1 and EMAP-II in relation to response of patients treated with TNF-based isolated limb perfusion.
van Horssen R; Rens JA; Brunstein F; Guns V; van Gils M; Hagen TL; Eggermont AM
Int J Cancer; 2006 Sep; 119(6):1481-90. PubMed ID: 16615114
[TBL] [Abstract][Full Text] [Related]
18. Cloning and expression of human endothelial-monocyte-activating polypeptide 2 (EMAP-2) and identification of its putative precursor.
Tas MP; Houghton J; Jakobsen AM; Tolmachova T; Carmichael J; Murray JC
Cytokine; 1997 Aug; 9(8):535-9. PubMed ID: 9245479
[TBL] [Abstract][Full Text] [Related]
19. Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiological processes.
van Horssen R; Eggermont AM; ten Hagen TL
Cytokine Growth Factor Rev; 2006 Oct; 17(5):339-48. PubMed ID: 16945568
[TBL] [Abstract][Full Text] [Related]
20. The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7.
Behrensdorf HA; van de Craen M; Knies UE; Vandenabeele P; Clauss M
FEBS Lett; 2000 Jan; 466(1):143-7. PubMed ID: 10648830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
